AzurRx BioPharma Inc Stock News

Reopening penny stocks that investors are watching right now The post 3 Reopening Penny Stocks to Watch in April 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c

DELRAY BEACH, Fla., April 15, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the develo

DELRAY BEACH, Fla., March 31, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the develo

Top-line data expected in Q2 2021 Top-line data expected in Q2 2021

The stock price of AzurRx BioPharma, Inc. (NASDAQ: AZRX) has increased by over 10% pre-market. This is why it happened.

Top-line data expected by end of Q1 2021

The stock price of AzurRx BioPharma Inc (NASDAQ: AZRX) has increased by over 40% pre-market. This is what you should know about the company.

DELRAY BEACH, Fla., March 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, r

AzurRx Chairman and CEO, James Sapirstein, to participate in panel discussion on potential developmental therapeutics for SARS-CoV-2 infection AzurRx Chairman and CEO, James Sapirstein, to participate

Former Chairman Edward J. Borkowski to continue as the lead independent director on the board Former Chairman Edward J. Borkowski to continue as the lead independent director on the board

Usana Health Sciences (NYSE: USNA) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued fiscal year 2021 EPS and sales guidance above estimates

Phase 2 Study of oral niclosamide planned for 1H 2021

DELRAY BEACH, Fla., Feb. 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, rec

$8 Million Offering to Fuel Acquisitions and Clinical Studies Leading Therapeutic for COVID-19 Related Gastrointestinal Infections. MS1819 a Better Mousetrap vs Porcine Competitors.

DELRAY BEACH, Fla., Jan. 28, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, rec